Get Real Time Here
| Open38.810 | Close39.130 |
| Vol / Avg.3.046M / 2.187M | Mkt Cap5.661B |
| Day Range38.470 - 40.900 | 52 Wk Range12.420 - 44.190 |
Immunovant Stock (NASDAQ:IMVT), Quotes and News Summary
Immunovant Stock (NASDAQ: IMVT) stock price, news, charts, stock research, profile.
| Open38.810 | Close39.130 |
| Vol / Avg.3.046M / 2.187M | Mkt Cap5.661B |
| Day Range38.470 - 40.900 | 52 Wk Range12.420 - 44.190 |
Earnings
see more| Q3 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2024 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.480 | -0.450 | 0.0300 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-15 | Truist Securities | Robyn Karnauskas | Maintains | BuyBuy | Raises | 30.00 | 48.00 |
| 2023-10-24 | Piper Sandler | Yasmeen Rahimi | Maintains | OverweightOverweight | Raises | 28.00 | 57.00 |
| 2023-10-24 | HC Wainwright & Co. | Douglas Tsao | Maintains | BuyBuy | Raises | 29.00 | 47.00 |
| 2023-10-16 | Cantor Fitzgerald | Louise Chen | Maintains | OverweightOverweight | Raises | 30.00 | 45.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IMVT | Immunovant | 2.33% | 5.7B |
| LEGN | Legend Biotech | 2.83% | 11.2B |
| EXAS | Exact Sciences | -1.63% | 11.6B |
| SRPT | Sarepta Therapeutics | 1.37% | 7.6B |
| NBIX | Neurocrine Biosciences | 2.69% | 11.5B |
How do I buy Immunovant (IMVT) stock?
You can purchase shares of Immunovant (NASDAQ: IMVT) through any online brokerage.
Who are Immunovant's (IMVT) competitors?
Other companies in Immunovant’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
What is the target price for Immunovant (IMVT) stock?
The latest price target for Immunovant (NASDAQ: IMVT) was reported by Truist Securities on Wednesday, November 15, 2023. The analyst firm set a price target for 48.00 expecting IMVT to rise to within 12 months (a possible 22.67% upside). 35 analyst firms have reported ratings in the last year.
Current Stock Price for Immunovant (IMVT)?
The stock price for Immunovant (NASDAQ: IMVT) is $39.13 last updated November 30, 2023 at 9:33 PM UTC.
Does Immunovant (IMVT) pay a dividend?
There is no dividend information for Immunovant.
When is Immunovant (NASDAQ:IMVT) reporting earnings?
Immunovant’s Q3 earnings are confirmed for Friday, February 2, 2024.
Is Immunovant (IMVT) going to split?
There is no upcoming split for Immunovant.
What sector and industry does Immunovant (IMVT) operate in?
Immunovant is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.